Mathieu R.
- Country
- France
- Department
- Medecine nucleaire
Research Overview
Data & Insights
Has run more than one trial at 25 of 25 partner sites.
Specializations
Urologic Oncology
The investigator specializes in the treatment of high-risk non-muscle invasive bladder cancer, developing innovative therapeutic approaches for patients who have not previously received BCG therapy. Their work encompasses evaluation of novel combination treatments and immunotherapeutic strategies.
- Bladder Cancer Management
- Intravesical Therapy Optimization
- Novel Treatment Combinations
Their expertise extends to investigating advanced therapeutic delivery systems and immunotherapy applications in bladder cancer treatment.
Prostate Cancer Diagnostics
The investigator focuses on advanced diagnostic imaging in prostate cancer, particularly utilizing innovative nuclear medicine techniques. Their research emphasizes the detection and assessment of lymph node metastases in high-risk prostate cancer patients.
- Molecular Imaging
- PSMA-Based Diagnostics
- Pre-surgical Staging
Their work involves evaluating cutting-edge imaging technologies for improved cancer staging and treatment planning.
Clinical Innovation
The investigator demonstrates expertise in diagnostic optimization and treatment assessment methodologies, particularly in urological cancers. Their work integrates advanced imaging techniques with therapeutic decision-making.
- Risk Stratification
- Treatment Response Assessment
- Diagnostic Protocol Development
Their research contributes to developing more precise and personalized approaches in urologic oncology.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.